182 related articles for article (PubMed ID: 21779873)
1. Association of the SLC30A8 missense polymorphism R325W with proinsulin levels at baseline and after lifestyle, metformin or troglitazone intervention in the Diabetes Prevention Program.
Majithia AR; Jablonski KA; McAteer JB; Mather KJ; Goldberg RB; Kahn SE; Florez JC;
Diabetologia; 2011 Oct; 54(10):2570-4. PubMed ID: 21779873
[TBL] [Abstract][Full Text] [Related]
2. Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish.
Maruthur NM; Clark JM; Fu M; Linda Kao WH; Shuldiner AR
Diabetologia; 2015 Feb; 58(2):295-303. PubMed ID: 25348609
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
Kirchhoff K; Machicao F; Haupt A; Schäfer SA; Tschritter O; Staiger H; Stefan N; Häring HU; Fritsche A
Diabetologia; 2008 Apr; 51(4):597-601. PubMed ID: 18264689
[TBL] [Abstract][Full Text] [Related]
4. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population.
Zheng X; Ren W; Zhang S; Liu J; Li S; Li J; Yang P; He J; Su S; Li P
Mol Biol Rep; 2012 Jan; 39(1):17-23. PubMed ID: 21437630
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets.
Cauchi S; Del Guerra S; Choquet H; D'Aleo V; Groves CJ; Lupi R; McCarthy MI; Froguel P; Marchetti P
Mol Genet Metab; 2010 May; 100(1):77-82. PubMed ID: 20138556
[TBL] [Abstract][Full Text] [Related]
6. hZnT8 (Slc30a8) Transgenic Mice That Overexpress the R325W Polymorph Have Reduced Islet Zn2+ and Proinsulin Levels, Increased Glucose Tolerance After a High-Fat Diet, and Altered Levels of Pancreatic Zinc Binding Proteins.
Li L; Bai S; Sheline CT
Diabetes; 2017 Feb; 66(2):551-559. PubMed ID: 27899481
[TBL] [Abstract][Full Text] [Related]
7. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
Moore AF; Jablonski KA; McAteer JB; Saxena R; Pollin TI; Franks PW; Hanson RL; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
Diabetes; 2008 Sep; 57(9):2503-10. PubMed ID: 18544707
[TBL] [Abstract][Full Text] [Related]
8. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
[TBL] [Abstract][Full Text] [Related]
9. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
[TBL] [Abstract][Full Text] [Related]
10. Zn(2+)-transporter-8: a dual role in diabetes.
Chistiakov DA; Voronova NV
Biofactors; 2009; 35(4):356-63. PubMed ID: 19655390
[TBL] [Abstract][Full Text] [Related]
11. The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.
Franks PW; Jablonski KA; Delahanty L; Hanson RL; Kahn SE; Altshuler D; Knowler WC; Florez JC;
Diabetologia; 2007 Dec; 50(12):2451-60. PubMed ID: 17898990
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the zinc transporter gene SLC30A8 confers resistance against posttransplantation diabetes mellitus in renal allograft recipients.
Kang ES; Kim MS; Kim YS; Kim CH; Han SJ; Chun SW; Hur KY; Nam CM; Ahn CW; Cha BS; Kim SI; Lee HC
Diabetes; 2008 Apr; 57(4):1043-7. PubMed ID: 18162509
[TBL] [Abstract][Full Text] [Related]
13. Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
Knowler WC; Hamman RF; Edelstein SL; Barrett-Connor E; Ehrmann DA; Walker EA; Fowler SE; Nathan DM; Kahn SE;
Diabetes; 2005 Apr; 54(4):1150-6. PubMed ID: 15793255
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione.
Kautzky-Willer A; Tura A; Winzer C; Wagner OF; Ludvik B; Hanusch-Enserer U; Prager R; Pacini G
Diabetes Obes Metab; 2006 Sep; 8(5):561-7. PubMed ID: 16918591
[TBL] [Abstract][Full Text] [Related]
15. The influence of rare genetic variation in SLC30A8 on diabetes incidence and β-cell function.
Billings LK; Jablonski KA; Ackerman RJ; Taylor A; Fanelli RR; McAteer JB; Guiducci C; Delahanty LM; Dabelea D; Kahn SE; Franks PW; Hanson RL; Maruthur NM; Shuldiner AR; Mayer-Davis EJ; Knowler WC; Florez JC;
J Clin Endocrinol Metab; 2014 May; 99(5):E926-30. PubMed ID: 24471563
[TBL] [Abstract][Full Text] [Related]
16. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients.
Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ
Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084
[TBL] [Abstract][Full Text] [Related]
17. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
Frias JP; Yu JG; Kruszynska YT; Olefsky JM
Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
Maggs DG; Buchanan TA; Burant CF; Cline G; Gumbiner B; Hsueh WA; Inzucchi S; Kelley D; Nolan J; Olefsky JM; Polonsky KS; Silver D; Valiquett TR; Shulman GI
Ann Intern Med; 1998 Feb; 128(3):176-85. PubMed ID: 9454525
[TBL] [Abstract][Full Text] [Related]
19. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance.
Tamaki M; Fujitani Y; Hara A; Uchida T; Tamura Y; Takeno K; Kawaguchi M; Watanabe T; Ogihara T; Fukunaka A; Shimizu T; Mita T; Kanazawa A; Imaizumi MO; Abe T; Kiyonari H; Hojyo S; Fukada T; Kawauchi T; Nagamatsu S; Hirano T; Kawamori R; Watada H
J Clin Invest; 2013 Oct; 123(10):4513-24. PubMed ID: 24051378
[TBL] [Abstract][Full Text] [Related]
20. Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and type 2 diabetes.
Shan Z; Bao W; Zhang Y; Rong Y; Wang X; Jin Y; Song Y; Yao P; Sun C; Hu FB; Liu L
Diabetes; 2014 May; 63(5):1796-803. PubMed ID: 24306209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
